Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  198.43
-0.36 (-0.18%)
AAPL  259.40
+3.62 (1.42%)
AMD  195.53
-11.79 (-5.69%)
BAC  53.21
+0.66 (1.26%)
GOOG  298.95
-7.07 (-2.31%)
META  632.80
-6.97 (-1.09%)
MSFT  396.86
-4.46 (-1.11%)
NVDA  179.65
-3.16 (-1.73%)
ORCL  154.72
-5.42 (-3.39%)
TSLA  402.38
-15.06 (-3.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.